Nerviano Medical Sciences is the largest pharmaceutical R&D facility in Italy and one of the largest oncology-focused, integrated discovery and development companies in Europe.
14/10/2009
Nerviano Medical Sciences: the SIF – Farmindustria prize for pharmacological research awarded to Paolo Cappella
08/10/2009
In JCO, Danusertib results of a Phase 1 trial. Phase 2 in patients with lung cancer and other solid tumors ongoing.
25/09/2009
Dr. Artur Góra guest at the Oncology Seminar at Nerviano Medical Sciences
Nerviano Medical Sciences: the SIF – Farmindustria prize for pharmacological research awarded to Paolo Cappella
08/10/2009
In JCO, Danusertib results of a Phase 1 trial. Phase 2 in patients with lung cancer and other solid tumors ongoing.
25/09/2009
Dr. Artur Góra guest at the Oncology Seminar at Nerviano Medical Sciences
© Nerviano Medical Sciences
VAT No. 04379750963